Puma Biotechnology Sees Q1 Sales $42.500M-$45.500M vs $47.50M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $42.500 million-$45.500 million vs $47.50 million analyst estimate.
Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $42.500 million-$45.500 million vs $47.50 million analyst estimate.